Editorial
Copyright ©The Author(s) 2024.
World J Gastroenterol. Dec 21, 2024; 30(47): 4983-4990
Published online Dec 21, 2024. doi: 10.3748/wjg.v30.i47.4983
Figure 2
Figure 2 Differences in treatment perspectives. A: Drug-eluting bead transarterial chemoembolization (TACE) is more favored in Western countries; B: Conventional transarterial chemoembolization is more favored in Eastern countries.; C: Describe the common causes of liver disease in the Western and Eastern regions, where the group of causes for liver disease in the West includes hepatitis C virus, alcohol-related liver disease, and metabolic-related liver disease, while in the East it includes viral hepatitis in general, use of hepatotoxic drugs, and alcohol consumption; D: Indications for TACE treatment in liver cancer patients. DEB-TACE: Drug-eluting bead transarterial chemoembolization; cTACE: Conventional transarterial chemoembolization.